다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Blueprint Medicines Corporation (BPMC)
Blueprint Medicines Corporation (BPMC) 뉴스

BPMC

Blueprint Medicines (BPMC)

Blueprint Medicines Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BPMC

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/12/21	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/12/21	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/12/20	07:17	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/12/19	06:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/12/18	22:00	PR Newswire (US)	Blueprint Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/12/17	09:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/12/13	06:52	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/12/08	02:30	PR Newswire (US)	Blueprint Medicines' Continued Leadership in Redefining the Standard of Care in Systemic Mastocytosis Highlighted at 2024 ASH Annual Meeting	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/12/04	07:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/12/03	08:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/11/30	03:40	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/11/28	08:51	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/11/23	06:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/11/22	06:23	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/11/21	06:30	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/11/13	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/11/13	03:44	Edgar (US Regulatory)	Form 144/A - Report of proposed sale of securities: [Amend]	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/11/08	07:24	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/10/31	05:27	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/10/30	20:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/10/30	20:00	PR Newswire (US)	Blueprint Medicines Reports Third Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/10/16	21:00	PR Newswire (US)	Blueprint Medicines to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/10/05	06:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/09/12	05:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/09/10	21:00	PR Newswire (US)	Blueprint Medicines to Present at Upcoming Investor Conferences	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/09/10	10:22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/08/20	05:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/08/16	05:27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/08/08	06:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BPMC	Blueprint Medicines Corporation
2024/08/06	05:50	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BPMC	Blueprint Medicines Corporation

검색 관련기사 보기:NASDAQ:BPMC

1 2 3 4 5 6 7 8 9 10 다음 >>

American Express

JP Morgan Chase

US Dollar vs Sterling

Deutsche Telekom (QX)

BNP Paribas (QX)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관